CN101352564B - 回生再造丸的新的医药用途 - Google Patents
回生再造丸的新的医药用途 Download PDFInfo
- Publication number
- CN101352564B CN101352564B CN2008101958099A CN200810195809A CN101352564B CN 101352564 B CN101352564 B CN 101352564B CN 2008101958099 A CN2008101958099 A CN 2008101958099A CN 200810195809 A CN200810195809 A CN 200810195809A CN 101352564 B CN101352564 B CN 101352564B
- Authority
- CN
- China
- Prior art keywords
- radix
- rhizoma
- processed
- treatment
- huisheng
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000006187 pill Substances 0.000 title claims abstract description 10
- 208000018737 Parkinson disease Diseases 0.000 claims abstract description 23
- 239000003814 drug Substances 0.000 claims abstract description 22
- 229940079593 drug Drugs 0.000 claims abstract description 9
- 241000271039 Agkistrodon Species 0.000 claims abstract description 8
- 238000002360 preparation method Methods 0.000 claims abstract description 6
- 239000000796 flavoring agent Substances 0.000 claims description 8
- 235000019634 flavors Nutrition 0.000 claims description 8
- 239000000843 powder Substances 0.000 claims description 8
- 241000209020 Cornus Species 0.000 claims description 6
- 235000021419 vinegar Nutrition 0.000 claims description 6
- 239000000052 vinegar Substances 0.000 claims description 6
- 241000522620 Scorpio Species 0.000 claims description 5
- 239000009490 scorpio Substances 0.000 claims description 5
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 4
- 241000255791 Bombyx Species 0.000 claims description 4
- 241000283956 Manis Species 0.000 claims description 3
- 235000012907 honey Nutrition 0.000 claims description 3
- 241000242759 Actiniaria Species 0.000 claims description 2
- 241000489492 Arisaema Species 0.000 claims description 2
- 241000717739 Boswellia sacra Species 0.000 claims description 2
- 241000903946 Clematidis Species 0.000 claims description 2
- 241000756943 Codonopsis Species 0.000 claims description 2
- 241000628997 Flos Species 0.000 claims description 2
- 239000004863 Frankincense Substances 0.000 claims description 2
- 239000009636 Huang Qi Substances 0.000 claims description 2
- 241001057584 Myrrha Species 0.000 claims description 2
- 241000237636 Pheretima Species 0.000 claims description 2
- 241001619461 Poria <basidiomycete fungus> Species 0.000 claims description 2
- RSWGJHLUYNHPMX-ONCXSQPRSA-N abietic acid Chemical compound C([C@@H]12)CC(C(C)C)=CC1=CC[C@@H]1[C@]2(C)CCC[C@@]1(C)C(O)=O RSWGJHLUYNHPMX-ONCXSQPRSA-N 0.000 claims description 2
- 210000000941 bile Anatomy 0.000 claims description 2
- 239000009286 sanguis draxonis Substances 0.000 claims description 2
- 210000000582 semen Anatomy 0.000 claims description 2
- 235000012239 silicon dioxide Nutrition 0.000 claims description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 16
- 206010008190 Cerebrovascular accident Diseases 0.000 abstract description 6
- 208000006011 Stroke Diseases 0.000 abstract description 6
- 241001465754 Metazoa Species 0.000 abstract description 2
- 241000283966 Pholidota <mammal> Species 0.000 abstract 1
- 241000239226 Scorpiones Species 0.000 abstract 1
- 230000003213 activating effect Effects 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- 239000004615 ingredient Substances 0.000 abstract 1
- 206010044565 Tremor Diseases 0.000 description 12
- 208000024891 symptom Diseases 0.000 description 11
- VYFYYTLLBUKUHU-UHFFFAOYSA-N dopamine Chemical compound NCCC1=CC=C(O)C(O)=C1 VYFYYTLLBUKUHU-UHFFFAOYSA-N 0.000 description 8
- 230000003203 everyday effect Effects 0.000 description 7
- 208000006083 Hypokinesia Diseases 0.000 description 5
- 230000003483 hypokinetic effect Effects 0.000 description 5
- WTDRDQBEARUVNC-LURJTMIESA-N L-DOPA Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-LURJTMIESA-N 0.000 description 4
- WTDRDQBEARUVNC-UHFFFAOYSA-N L-Dopa Natural products OC(=O)C(N)CC1=CC=C(O)C(O)=C1 WTDRDQBEARUVNC-UHFFFAOYSA-N 0.000 description 4
- 206010061533 Myotonia Diseases 0.000 description 4
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 4
- 229960004373 acetylcholine Drugs 0.000 description 4
- 229960003638 dopamine Drugs 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000005036 nerve Anatomy 0.000 description 4
- 230000001225 therapeutic effect Effects 0.000 description 4
- 208000002740 Muscle Rigidity Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 230000003291 dopaminomimetic effect Effects 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 230000035807 sensation Effects 0.000 description 3
- 235000019615 sensations Nutrition 0.000 description 3
- YJPIGAIKUZMOQA-UHFFFAOYSA-N Melatonin Natural products COC1=CC=C2N(C(C)=O)C=C(CCN)C2=C1 YJPIGAIKUZMOQA-UHFFFAOYSA-N 0.000 description 2
- 229940121948 Muscarinic receptor antagonist Drugs 0.000 description 2
- 208000027089 Parkinsonian disease Diseases 0.000 description 2
- 206010034010 Parkinsonism Diseases 0.000 description 2
- 208000019802 Sexually transmitted disease Diseases 0.000 description 2
- HWHLPVGTWGOCJO-UHFFFAOYSA-N Trihexyphenidyl Chemical compound C1CCCCC1C(C=1C=CC=CC=1)(O)CCN1CCCCC1 HWHLPVGTWGOCJO-UHFFFAOYSA-N 0.000 description 2
- BNQDCRGUHNALGH-UHFFFAOYSA-N benserazide Chemical compound OCC(N)C(=O)NNCC1=CC=C(O)C(O)=C1O BNQDCRGUHNALGH-UHFFFAOYSA-N 0.000 description 2
- 229960000911 benserazide Drugs 0.000 description 2
- 230000017531 blood circulation Effects 0.000 description 2
- 230000008859 change Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 229940126678 chinese medicines Drugs 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 235000009508 confectionery Nutrition 0.000 description 2
- 230000005284 excitation Effects 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- DRLFMBDRBRZALE-UHFFFAOYSA-N melatonin Chemical compound COC1=CC=C2NC=C(CCNC(C)=O)C2=C1 DRLFMBDRBRZALE-UHFFFAOYSA-N 0.000 description 2
- 229960003987 melatonin Drugs 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 239000002304 perfume Substances 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 229960001032 trihexyphenidyl Drugs 0.000 description 2
- TZFNLOMSOLWIDK-SNVBAGLBSA-N (2r)-2-(aminoazaniumyl)-3-(3,4-dihydroxyphenyl)-2-methylpropanoate Chemical compound NN[C@](C(O)=O)(C)CC1=CC=C(O)C(O)=C1 TZFNLOMSOLWIDK-SNVBAGLBSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 206010002198 Anaphylactic reaction Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 206010013887 Dysarthria Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000001953 Hypotension Diseases 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- 206010062575 Muscle contracture Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 208000000418 Premature Cardiac Complexes Diseases 0.000 description 1
- 208000013738 Sleep Initiation and Maintenance disease Diseases 0.000 description 1
- 208000001871 Tachycardia Diseases 0.000 description 1
- 241000396377 Tranes Species 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 230000036783 anaphylactic response Effects 0.000 description 1
- 208000003455 anaphylaxis Diseases 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000001713 cholinergic effect Effects 0.000 description 1
- 208000006111 contracture Diseases 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002964 excitative effect Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000036543 hypotension Effects 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 206010022437 insomnia Diseases 0.000 description 1
- 210000001259 mesencephalon Anatomy 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000002569 neuron Anatomy 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- WYDUSKDSKCASEF-UHFFFAOYSA-N procyclidine Chemical compound C1CCCCC1C(C=1C=CC=CC=1)(O)CCN1CCCC1 WYDUSKDSKCASEF-UHFFFAOYSA-N 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000001953 sensory effect Effects 0.000 description 1
- 208000026473 slurred speech Diseases 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000006794 tachycardia Effects 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101958099A CN101352564B (zh) | 2008-09-03 | 2008-09-03 | 回生再造丸的新的医药用途 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN2008101958099A CN101352564B (zh) | 2008-09-03 | 2008-09-03 | 回生再造丸的新的医药用途 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101352564A CN101352564A (zh) | 2009-01-28 |
CN101352564B true CN101352564B (zh) | 2011-12-28 |
Family
ID=40305743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008101958099A Active CN101352564B (zh) | 2008-09-03 | 2008-09-03 | 回生再造丸的新的医药用途 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101352564B (zh) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102755490B (zh) * | 2012-07-03 | 2013-10-23 | 杨振刚 | 九香散加味治疗帕金森病 |
CN103610870B (zh) * | 2013-12-12 | 2016-04-13 | 侯书圣 | 一种治疗心脑血管疾病的中药制剂 |
CN107789504B (zh) * | 2017-11-27 | 2021-01-29 | 成都中医药大学 | 一种治疗帕金森综合症的药物组合物及其制备方法和用途 |
-
2008
- 2008-09-03 CN CN2008101958099A patent/CN101352564B/zh active Active
Non-Patent Citations (1)
Title |
---|
郑春叶,雒晓东,孙玉芝,等.<中医辨证治疗帕金森病进展述评>.<新中医>.2004,第36卷(第1期),第73-75页. * |
Also Published As
Publication number | Publication date |
---|---|
CN101352564A (zh) | 2009-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101537168B (zh) | 一种治疗颈椎病及骨关节疾病的中药组合物及其制备方法 | |
CN100361704C (zh) | 一种治疗风湿、骨关节疾病的药酒 | |
CN101757569A (zh) | 一种治疗脑血栓、脑梗塞的中药组合物及其制备方法 | |
CN101732616B (zh) | 一种治疗脑溢血的中药组合物及其制备方法 | |
CN100473411C (zh) | 偏瘫脑络康纯中草药剂 | |
CN101773650A (zh) | 一种治疗抽搐的中药组合物及其制备方法 | |
CN103316130A (zh) | 一种治疗三叉神经痛的中药组合物 | |
CN1335162A (zh) | 治疗颈、腰椎间盘突出的药物 | |
CN103386016B (zh) | 通血活络丸 | |
CN102813839A (zh) | 治疗血管神经性头痛的复方药物 | |
CN102670776A (zh) | 用于治疗痹症的中药组合物 | |
CN102274378A (zh) | 一种治疗脑血管疾病的健脑防栓丸及其制备方法 | |
CN101352564B (zh) | 回生再造丸的新的医药用途 | |
CN101590104A (zh) | 一种治疗阻塞性脉管炎的中药 | |
CN103816476A (zh) | 一种治疗动眼神经损伤麻痹的药物组合物及其制备方法和应用 | |
CN101062362A (zh) | 一种治疗中风偏瘫及后遗症的中药制剂 | |
CN1853679A (zh) | 一种治疗颈椎病的药物组合物及其制备方法 | |
CN102008551B (zh) | 一种治疗颈、肩、臂疼痛的药物组合物及其制备方法和用途 | |
CN103495042A (zh) | 一种用于治偏头痛的中药组合物 | |
CN103721082B (zh) | 一种治疗肩周炎的中药组合物 | |
CN1324650A (zh) | 治疗顽症颈椎病的特效方药 | |
CN103830672A (zh) | 一种用于治疗肩周炎的中药 | |
CN1286500C (zh) | 治疗关节疼痛的药物 | |
CN102430030B (zh) | 一种治疗骨痹的中药组合物 | |
CN101041021A (zh) | 一种内服治疗脑中风的中药组合物 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right | ||
TR01 | Transfer of patent right |
Effective date of registration: 20230920 Address after: No. 120 Daquan Road, Luqu District, Huangshi City, Hubei Province, 435000 Patentee after: LANGTIAN PHARMACEUTICAL (HUBEI) CO.,LTD. Patentee after: Hubei Langtian Pharmaceutical Co.,Ltd. Address before: 232008 Huainan economic and Technological Development Zone, Anhui Patentee before: Toshiba Hall pharmaceutical (Anhui) Co.,Ltd. |
|
CI03 | Correction of invention patent | ||
CI03 | Correction of invention patent |
Correction item: Address Correct: No. 120 Daquan Road, Xialu District, Huangshi City, Hubei Province, 435000 False: No. 120 Daquan Road, Luqu District, Huangshi City, Hubei Province, 435000 Number: 40-01 Volume: 39 |